How Aspen is convincing the sceptics
Aspen is winning over the doubters after slashing debt and clinching the J&J deal. But it needs to build on its promises
The term "Big Pharma" carries plenty of derogatory connotations. And even consumers who don’t subscribe to conspiracies involving vaccines and microchips love to hate drug companies.
But last Thursday was a chance for Aspen Pharmacare’s founder, Stephen Saad, to reflect on the progress his company has made in recent months...